PainReform Ltd. (PRFX): Price and Financial Metrics
GET POWR RATINGS... FREE!
PRFX Stock Price Chart Interactive Chart >
PRFX Price/Volume Stats
| Current price | $0.90 | 52-week high | $7.84 |
| Prev. close | $0.95 | 52-week low | $0.71 |
| Day low | $0.89 | Volume | 10,900 |
| Day high | $0.95 | Avg. volume | 84,231 |
| 50-day MA | $0.94 | Dividend yield | N/A |
| 200-day MA | $1.50 | Market Cap | 9.43M |
PainReform Ltd. (PRFX) Company Bio
PainReform Ltd. operates as a pharmaceutical company. It develops and markets pharmaceuticals. The firm focuses on developing reformulation of pain therapeutics, PainReform applies its propriety formulation technologies to prolong and enhance efficacy, reduce adverse effects shortening recovery time and reduce the need of augmentation with drugs such as opioids and NSAIDS. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.
Latest PRFX News From Around the Web
Below are the latest news stories about Painreform Ltd that investors may wish to consider to help them evaluate PRFX as an investment opportunity.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayGrab a cup of coffee and get ready for another busy day of trading as we start with the biggest pre-market stock movers for Tuesday! |
PainReform CEO to Participate in the Benzinga All Access Event on December 16thTEL AVIV, Israel, Dec. 14, 2021 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that Ilan Hadar, Chief Executive Officer of PainReform, will be participating in the Benzinga All Access event taking place on December 16, 2021. Mr. Hadar is scheduled to appear on December 16, 2021 at 10:00 A.M. Eastern Time. The event will consist of an int |
AUPH Stock: 13 Things to Know About Aurinia Pharma as Shares Crash TodayAurinia Pharma (AUPH) stock is taking a beating on Monday following a filing with the SEC after markets closed on Friday. |
PRFX Stock: 8 Things to Know About PainReform as Shares Trend on Unusually Heavy Volume TodayPainReform (PRFX) stock is on the move Monday with heavy trading despite a lack of news coming from the medical device company. |
Rivian News: 12 Things for RIVN Stock Investors to Know About a Potential Deal With RV Rental Company OutdoorsyRivian (RIVN) stock is in the news today thanks to talk from Outdoorsy about a potential deal for electric vehicles (EVs). |
PRFX Price Returns
| 1-mo | -11.76% |
| 3-mo | -23.08% |
| 6-mo | -32.33% |
| 1-year | -67.15% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -32.33% |
| 2021 | -70.25% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...